CVE-2026-41360 Details
Description
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
A vulnerability exists in OpenClaw versions prior to 2026.4.2, specifically within the pnpm dlx command. This vulnerability allows for an approval integrity bypass, as the tool fails to consistently bind local script operands in a way that aligns with pnpm exec workflows. As a result, an attacker could replace an approved local script with a modified version before execution, without disrupting the approval plan. This flaw enables the execution of altered script contents, creating a potential security risk.
Users can update to OpenClaw version 2026.4.2 or later to address this vulnerability.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Apr 24, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-367 | Time-of-check Time-of-use (TOCTOU) Race Condition | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| openclaw openclaw | < 2026.4.2 |
CPE
Remediation
| |
Change History
4 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| May 1, 2026 | Initial Analysis | [email protected] |
| Apr 23, 2026 | New CVE Received | [email protected] |